The US Preventive Services Task Force (USPSTF) is expanding its recommendation for antiretrovirals in HIV now that more options are available on the market.
“With these new options we could potentially extend pre-exposure prophylaxis (PrEP) to a wider population,” says James Stevermer, MD, a member of the task force and a professor of family and community medicine at the University of Missouri, in Columbia. Read more in Medscape.